Implementing an Opioid Risk Reduction Program in the Acute Comprehensive Inpatient Rehabilitation Setting

Autor: Teresa Tang, Amira A. Noles, Ada Lyn Yao, Erik H. Hoyer, Nicholas Dabai, Margaret Kott, Stephanie P. Van, Alexis Coslick, Lee Ann Sprankle, Solomon Rojhani
Rok vydání: 2019
Předmět:
Zdroj: Archives of Physical Medicine and Rehabilitation. 100:1391-1399
ISSN: 0003-9993
DOI: 10.1016/j.apmr.2019.04.011
Popis: To describe the implementation and evaluation of an interdisciplinary quality improvement (QI) project to increase prescription of take-home naloxone (THN) to reduce risks associated with opioids for patients admitted to an acute inpatient rehabilitation unit.Prospective cohort quality improvement project.Eighteen-bed acute comprehensive inpatient rehabilitation (ACIR) unit at a large academic institution.Patients admitted to ACIR between December 2015-November 2016 (N=788).An interdisciplinary QI model comprised of planning, education, implementation, and maintenance was used to implement a THN and opioid risk-reduction program involving provider and patient education. Analyses consisted of comparisons between baseline, early, and late phases of the project.(1) The proportion of eligible patients who received a prescription for naloxone upon discharge from ACIR; (2) the proportion of patients originally admitted to ACIR on opioids that were weaned off upon discharge.The adjusted odds of eligible patients being discharged from ACIR with a naloxone prescription during the late QI period were 7 (95% confidence interval [CI]: 3-21) times higher than during the early QI period (late QI period: 43%, 95% CI: 25%-63%; early QI period: 10%, 95% CI: 3%-28%; P.001). For patients admitted on opioids, the adjusted odds of being weaned off opioids during the late QI period were 10 (95% CI: 4-25) times higher than during baseline (late QI period: 29%, 95% CI: 17%-45%; baseline: 4%, 95% CI: 1%-10%; P.001).Implementation of a THN and opioid risk reduction QI project in an inpatient rehabilitation setting led to significantly more eligible patients receiving naloxone and more patients weaned off schedule II opioids.
Databáze: OpenAIRE